Chromosomal damage induced by furocoumarins and UVA in hamster and human cells including cells from patients with ataxia telangiectasia and xeroderma pigmentosum
- 1 November 1981
- journal article
- research article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 84 (1) , 113-124
- https://doi.org/10.1016/0027-5107(81)90055-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- 5-Methoxypsoralen, an ingredient in several suntan preparations, has lethal, mutagenic and clastogenic propertiesNature, 1980
- Mutagenicity of 8-methoxypsoralen and long-wave ultraviolet irradiation in diploid human skin fibroblasts an imported risk estimate in photochemotherapyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1979
- Possible cancer hazard associated with 5-methoxypsoralen in suntan preparations.BMJ, 1979
- Risks and Benefits of the Treatment of PsoriasisNew England Journal of Medicine, 1979
- Mutagenicity of cross‐links and monoadducts of furocoumarins (psoralen and angelicin) induced by 360‐nm radiation in excision‐repair‐defective and radiation‐insensitive strains of saccharomyces cerevisiaeEnvironmental Mutagenesis, 1979
- Chromosome damage in chinese hamster cells sensitized to near-ultraviolet light by psoralen and angelicinMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1977
- Conversion of psoralen DNA monoadducts in E. coli to interstrand DNA cross links by near UV light (320–360 nm): Inability of angelicin to form cross links, in vivoCellular and Molecular Life Sciences, 1977
- Letter: Chromosome damage produced by psoralen and ultraviolet light.BMJ, 1976
- Formation of Inter-Strand Cross-Linkings in the Photoreactions between Furocoumarins and DNAZeitschrift für Naturforschung B, 1971
- The Wave Length Effect Upon Erythemal and Carcinogenic Response in Psoralen Treated Mice11From the Department of Biochemistry, The University of Texas M.D. Anderson Hospital and Tumor Institute and the Departments of Biochemistry and Dermatology, Baylor University College of Medicine, Houston, Texas. Supported by grants from the Robert A. Welch Foundation, Humble Oil and Refining Company and the National Cancer Institute (NCI 2620), U. S. Department of Health, Education and Welfare.Journal of Investigative Dermatology, 1958